Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;18(9):963-74.
doi: 10.1038/mp.2013.20. Epub 2013 Feb 26.

The vascular depression hypothesis: mechanisms linking vascular disease with depression

Affiliations
Review

The vascular depression hypothesis: mechanisms linking vascular disease with depression

W D Taylor et al. Mol Psychiatry. 2013 Sep.

Abstract

The 'Vascular Depression' hypothesis posits that cerebrovascular disease may predispose, precipitate or perpetuate some geriatric depressive syndromes. This hypothesis stimulated much research that has improved our understanding of the complex relationships between late-life depression (LLD), vascular risk factors, and cognition. Succinctly, there are well-established relationships between LLD, vascular risk factors and cerebral hyperintensities, the radiological hallmark of vascular depression. Cognitive dysfunction is common in LLD, particularly executive dysfunction, a finding predictive of poor antidepressant response. Over time, progression of hyperintensities and cognitive deficits predicts a poor course of depression and may reflect underlying worsening of vascular disease. This work laid the foundation for examining the mechanisms by which vascular disease influences brain circuits and influences the development and course of depression. We review data testing the vascular depression hypothesis with a focus on identifying potential underlying vascular mechanisms. We propose a disconnection hypothesis, wherein focal vascular damage and white matter lesion location is a crucial factor, influencing neural connectivity that contributes to clinical symptomatology. We also propose inflammatory and hypoperfusion hypotheses, concepts that link underlying vascular processes with adverse effects on brain function that influence the development of depression. Testing such hypotheses will not only inform the relationship between vascular disease and depression, but also provide guidance on the potential repurposing of pharmacological agents that may improve LLD outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed progression of etiological processes affecting frontolimbic function. After crossing an initial threshold, vascular or other processes may serve as one of many factors that increase vulnerability to depression through compromise of affective and cognitive brain circuits. As the underlying disease process progresses, its adverse effects on the affective and cognitive circuits would likewise increase, resulting in the circuit dysfunctions that characterize depression.
Figure 2
Figure 2
This model links the disconnection, inflammation, and hypoperfusion processes proposed in late-life depression. Vascular disease may contribute to altered brain function characteristic of depression (dorsal hypometabolism, ventral hypermetabolism) either through structural damage adversely affecting connectivity, through perfusion deficits altering regional function, or both. Proinflammatory processes increase vascular risk but may also affect brain function through independent processes. In this model, vascular disease is an important and central contributor to LLD. Not only is vascular disease common and perhaps unavoidable in later life, but it also interacts with other pathological processes related to depression. However, vascular disease is not the only contributor to LLD. Other biological and environmental factors can increase the risk for depression by alterating neural circuit structure and function. Similarly, genetic influences may increase risk of depression by acting at multiple points, such altering function of neural circuits, changing the biological response to stress, adding to vascular risk, or predisposing to proinflammatory states.

References

    1. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365:1961–1970. - PubMed
    1. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54(10):915–922. - PubMed
    1. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M. Clinically defined vascular depression. Am J Psychiatry. 1997;154(4):562–565. - PubMed
    1. Alexopoulos GS. “The Depression-Executive Dysfunction Syndrome of Late Life”: a specific target for D3 agonists? Am J Geriatr Psychiatry. 2001;9:22–29. - PubMed
    1. Krishnan KRR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154(4):497–501. - PubMed

Publication types